NCT03254459View on ClinicalTrials.gov

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

November 13, 2017

Study Completion Date

November 13, 2017

Conditions
Pain, Postoperative
Interventions
DRUG

Buprenorphine Sublingual Spray

0.5 mg Sublingual Spray

DRUG

Morphine

4 mg Intravenous Injection

DRUG

Oxycodone Hydrochloride

10 mg tablet

DRUG

Zofran

4 mg oral disintegrating tablet (ODT) or IV injection given at the investigator's discretion for nausea

Trial Locations (2)

84123

Epic Medical Research, Murray

91105

Lotus Clinical Research, LLC, Pasadena

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT03254459 - Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain | Biotech Hunter | Biotech Hunter